Alto Neuroscience, Inc. · NYSE:ANRO

Smith Nicholas Conrad sold 134,886 Alto Neuroscience, Inc. shares (Form 4)

Traded Sep 29 to Sep 30, 2026 · Filed Oct 1, 2026

From Sep 29 to Sep 30, 2026, Smith Nicholas Conrad (PRESIDENT AND CFO) sold 134,886 Alto Neuroscience, Inc. shares at an average US$26.45 for US$3.57M, leaving 24,060 shares. Filed Oct 1, 2026 (Form 4).

Sold
134,886 shares
Price
US$26.45 average (US$25.78 to US$26.87)
Value
US$3.57M
Holding after
24,060 shares
Trading plan
No
Role
PRESIDENT AND CFO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 29, 2026Common StockOption exercise56,455US$2.3580,515Direct
Sep 29, 2026Common StockOption exercise54,375US$2.35134,890Direct
Sep 29, 2026Common StockSale110,830US$26.5824,060Direct
Sep 30, 2026Common StockOption exercise24,056US$2.3548,116Direct
Sep 30, 2026Common StockSale23,170US$25.7824,946Direct
Sep 30, 2026Common StockSale886US$26.8724,060Direct

Source

View original at SEC

Related